IBO’s company of the year for 2021 is Thermo Fisher Scientific. During 2021, Thermo Fisher balanced the demands of recent and pending major acquisitions (see IBO 4/16/21), the unpredictable COVID-19 marketplace, the roll out of multiple new products and a commitment to the fundamentals of its business strategy. IBO selects a company of the year […]
The 2020 SDi Global Assessment has been updated for the first time in the publication history of the report in response to the COVID-19 Pandemic. The 2020 SDi Global Assessment Report contains insights into the impact of the COVID-19 pandemic on the global instrumentation industry. With this completely updated report and a new add-on item, the Global Quarterly Datastream, your company can leverage […]
As COVID-19 has spread from its origins to almost every corner of the world over the past six months, it has engendered major changes around the globe. The virus has caused a global slowdown due to lockdowns, supply chain disruptions, and reduced production levels, while also stimulating a vaccine race among pharmaceuticals and biotech companies. […]
The world has been justly preoccupied with the spread of COVID-19 throughout the world and its effects on human health. From a science standpoint, the life science and analytical instrumentation industry has responded to help combat the disease, by supporting research into better diagnosis, treatment, and prevention of the disease. From a business perspective, there […]
While standard viral tests involving PCR are the primary way to diagnose an active COVID-19 infection, researchers are naturally pursuing alternatives that may provide other advantages. Currently, there is a focus on developing antibody tests, for instance, which could also determine whether a patient had previously been infected, helping epidemiologists better understand the spread of […]
The latest report from SDi examines the bioprocessing market which they project will grow at a compound annual growth rate (CAGR) of 9.0% during the next five years. The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. […]
As of April 2020, the COVID-19 pandemic has infected millions and killed more than one hundred thousand people, requiring lockdowns and social distancing measures that, in turn, greatly hurt the profitability of many industries. The pharmaceutical industry is no exception to the economic downturn, despite its activities being more important than ever.
For the past year, the upstream oil industry has suffered from low crude oil prices, which translates to less revenue for oil producers. The situation started when the US succeeded in shale oil and gas exploration, which doubled its production volume since 2009. With the sudden increase in supply, the oil price tumbled down as […]
The chromatography market includes both gas and liquid separation techniques. All chromatography instruments incorporate the following: a sample-introduction port of some type; a delivery system for a mobile phase carrier which moves the sample through the system; a stationary phase, which may be held within a column, a capillary and one or more detectors that […]
SDi released its flagship 2020 Global Assessment Report at the end of February, which provides detailed market data for 83 categories of lab instruments, with revenues coming from over 1,200 supplier companies. Though the early part of 2020 had a rosier outlook for the year, laboratory suppliers have just recently had to adapt to […]
June 14, 2021 1:52 pm
April 27, 2021 7:19 am
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.